Hantz Financial Services’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Other funds holding BBH
MIM
BFG
CCA
Hantz Financial Services's BBH Position: Q4 2025 in Review
Hantz Financial Services sold out of VanEck Biotech ETF (BBH) in Q4 2025, closing a stake of 25 shares — an estimated $4K sold.
Hantz Financial Services first reported a position in BBH in Q3 2025 and held it in 1 quarter. The position peaked at $4K in Q3 2025. 111 funds tracked by Wall St. Rank hold BBH as of Q4 2025.
- Hantz Financial Services reported no remaining VanEck Biotech ETF position as of Q4 2025 after selling out during the quarter.
- Hantz Financial Services sold 25 VanEck Biotech ETF shares in Q4 2025, an estimated $4K.
- Hantz Financial Services first reported a position in VanEck Biotech ETF in Q3 2025 and held it in 1 quarter.
- Hantz Financial Services's VanEck Biotech ETF position peaked at $4K in Q3 2025.
- 111 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2025.
Based on Hantz Financial Services's 13F filing for Q4 2025, filed 9 Feb 2026.